Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | TP53 | P04637 | 1/20 | 0.71 |
| ▸ | GLA | P06280 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.71 |
| ▸ | FLT1 | P17948 | 4/20 | 0.53 |
| ▸ | FLT4 | P35916 | 4/20 | 0.53 |
| ▸ | KDR | P35968 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glyclopyramide SCHEMBL15669226 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Glypinamide SCHEMBL343885 | 0.98 | ALDH1A1 (0.74) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Tolazamide SCHEMBL34417 | 0.83 | ALDH1A1 (1.00) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Tolazamide SCHEMBL13725632 | 0.83 | ALDH1A1 (1.00) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Tolazamide SCHEMBL2534564 | 0.82 | ALDH1A1 (0.70) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Tolazamide SCHEMBL28562527 | 0.82 | ALDH1A1 (0.97) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| SCHEMBL11627200 | 0.82 | MCHR1 (0.59) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| SCHEMBL11626350 | 0.82 | MCHR1 (0.59) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Glypinamide SCHEMBL5243890 | 0.81 | ALDH1A1 (0.59) | ALDH1A1CYP3A4NFKB1MAPTKDM4E | |
| Acetohexamide SCHEMBL20267964 | 0.81 | ALDH1A1 (0.73) | ALDH1A1CYP3A4NFKB1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4361 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684799-A2 | ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF | TrueBinding, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4640701-A2 | GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF | Janssen Sciences Ireland Unlimited Company (IE) | 2025-10-29 | — | — | EP | claimed |
| US-20250325536-A1 | THERAPEUTIC USES OF GLP1R AGONISTS | VTV THERAPEUTICS LLC (US) | 2025-10-23 | — | — | US | claimed |
| EP-4520343-A2 | GLUCAGON LIKE PEPTIDE 1 (GLP1)-GROWTH DIFFERENTIATION FACTOR 15 (GDF15) FUSION PROTEINS AND USES THEREOF | Janssen Sciences Ireland Unlimited Company (IE) | 2025-03-12 | — | — | EP | claimed |
| EP-3988123-B1 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | JANSSEN PHARMACEUTICA NV (BE) | 2025-02-26 | — | — | EP | claimed |
| US-20240065979-A1 | Protection of Polyunsaturated Fatty Acids, Lipid-Soluble Vitamins, and Lipid-Soluble Medicaments from Oxidation | One Idea LLC (US) | 2024-02-29 | — | — | US | claimed |
| EP-4271371-A1 | PROTECTION OF POLYUNSATURATED FATTY ACIDS, LIPID-SOLUBLE VITAMINS, AND LIPID-SOLUBLE MEDICAMENTS FROM OXIDATION | One Idea LLC (US) | 2023-11-08 | — | — | EP | claimed |
| EP-4232448-A1 | AGONISTS OF FREE FATTY ACID RECEPTOR 1 AND THEIR USE IN DISEASES ASSOCIATED WITH SAID RECEPTOR | Halo Therapeutics Ltd (GB) | 2023-08-30 | — | — | EP | claimed |
| US-11732019-B2 | Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors | JANSSEN PHARMACEUTICA NV (BE) | 2023-08-22 | — | — | US | claimed |
| WO-2023084320-A1 | RECONSTITUTABLE, SINGLE USE ANTIDIABETIC COMPOSITIONS | V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED (IN) | 2023-05-19 | — | — | WO | claimed |
| CN-1348369-A | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent | SMITHKLINE BEECHAM PLC (GB) | 2002-05-08 | — | — | CN | claimed |
| WO-2002005795-A2 | PHARMACEUTICAL COMBINATIONS FOR TREATMENT AND PREVENTION OF DIABETES MELLITUS | Kéri Pharma Kft. (HU) | 2002-01-24 | — | — | WO | claimed |
| CN-1332638-A | Combination comprising beta-agonist and further antidiabetic agent | SMITHKLINE BEECHHAM P L C (GB) | 2002-01-23 | — | — | CN | claimed |
| US-6329404-B1 | Pharmaceutical composition | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-12-11 | — | — | US | claimed |
| US-6303640-B1 | ADMINISTERING OXAZOLE OR THIAZOLE DERIVATIVE COMPOUND FOR REDUCING SIDE EFFECTS OF DIABETIC THERAPY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-10-16 | — | — | US | claimed |
| US-6211205-B1 | ANTIDIABETIC AGENTS THAT ENHANCE INSULIN SECRETION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-03 | — | — | US | claimed |
| US-6150383-A | COMPRISING AN INSULIN SENSITIVITY ENHANCER IN COMBINATION WITH ONE OR MORE OTHER ANTIDIABETICS DIFFERING FROM THE ENHANCER IN MECHANISM OF ACTION; LIPID/GLYCOMETABOLISM DISORDERS; ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-11-21 | — | — | US | claimed |
| CN-1264302-A | Treatment of diabetes with thiazolidinediones and sulfonylureas | SMITHKLINE BEECHAM PLC (GB) | 2000-08-23 | — | — | CN | claimed |
| CN-1263467-A | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor | SMITHKLINE BEECHAM PLC (GB) | 2000-08-16 | — | — | CN | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |